Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.

BACKGROUND: Maturity-onset diabetes of the young (MODY) is uncommon; however, accurate diagnosis facilitates personalized management and informs prognosis in probands and relatives. OBJECTIVE: The objective of the study was to highlight that the appropriate use of genetic and nongenetic investigatio...

Full description

Bibliographic Details
Main Authors: Kavvoura, F, Raimondo, A, Thanabalasingham, G, Barrett, A, Webster, A, Shears, D, Mann, N, Ellard, S, Gloyn, A, Owen, K
Format: Journal article
Language:English
Published: 2014
_version_ 1797062218785751040
author Kavvoura, F
Raimondo, A
Thanabalasingham, G
Barrett, A
Webster, A
Shears, D
Mann, N
Ellard, S
Gloyn, A
Owen, K
author_facet Kavvoura, F
Raimondo, A
Thanabalasingham, G
Barrett, A
Webster, A
Shears, D
Mann, N
Ellard, S
Gloyn, A
Owen, K
author_sort Kavvoura, F
collection OXFORD
description BACKGROUND: Maturity-onset diabetes of the young (MODY) is uncommon; however, accurate diagnosis facilitates personalized management and informs prognosis in probands and relatives. OBJECTIVE: The objective of the study was to highlight that the appropriate use of genetic and nongenetic investigations leads to the correct classification of diabetes etiology. CASE DISCUSSION: A 30-year-old European female was diagnosed with insulin-treated gestational diabetes. She discontinued insulin after delivery; however, her fasting hyperglycemia persisted. β-Cell antibodies were negative and C-peptide was 0.79 nmol/L. Glucokinase (GCK)-MODY was suspected and confirmed by the identification of a GCK mutation (p.T206M). METHODS: Systematic clinical and biochemical characterization and GCK mutational analysis were implemented to determine the diabetes etiology in five relatives. Functional characterization of GCK mutations was performed. RESULTS: Identification of the p.T206M mutation in the proband's sister confirmed a diagnosis of GCK-MODY. Her daughter was diagnosed at 16 weeks with permanent neonatal diabetes (PNDM). Mutation analysis identified two GCK mutations that were inherited in trans-p. [(R43P);(T206M)], confirming a diagnosis of GCK-PNDM. Both mutations were shown to be kinetically inactivating. The proband's mother, other sister, and daughter all had a clinical diagnosis of type 1 diabetes, confirmed by undetectable C-peptide levels and β-cell antibody positivity. GCK mutations were not detected. CONCLUSIONS: Two previously misclassified family members were shown to have GCK-MODY, whereas another was shown to have GCK-PNDM. A diagnosis of type 1 diabetes was confirmed in three relatives. This family exemplifies the importance of careful phenotyping and systematic evaluation of relatives after discovering monogenic diabetes in an individual.
first_indexed 2024-03-06T20:42:23Z
format Journal article
id oxford-uuid:34b580bd-0707-43d2-b321-2b1f8ab4803f
institution University of Oxford
language English
last_indexed 2024-03-06T20:42:23Z
publishDate 2014
record_format dspace
spelling oxford-uuid:34b580bd-0707-43d2-b321-2b1f8ab4803f2022-03-26T13:27:38ZReclassification of diabetes etiology in a family with multiple diabetes phenotypes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:34b580bd-0707-43d2-b321-2b1f8ab4803fEnglishSymplectic Elements at Oxford2014Kavvoura, FRaimondo, AThanabalasingham, GBarrett, AWebster, AShears, DMann, NEllard, SGloyn, AOwen, KBACKGROUND: Maturity-onset diabetes of the young (MODY) is uncommon; however, accurate diagnosis facilitates personalized management and informs prognosis in probands and relatives. OBJECTIVE: The objective of the study was to highlight that the appropriate use of genetic and nongenetic investigations leads to the correct classification of diabetes etiology. CASE DISCUSSION: A 30-year-old European female was diagnosed with insulin-treated gestational diabetes. She discontinued insulin after delivery; however, her fasting hyperglycemia persisted. β-Cell antibodies were negative and C-peptide was 0.79 nmol/L. Glucokinase (GCK)-MODY was suspected and confirmed by the identification of a GCK mutation (p.T206M). METHODS: Systematic clinical and biochemical characterization and GCK mutational analysis were implemented to determine the diabetes etiology in five relatives. Functional characterization of GCK mutations was performed. RESULTS: Identification of the p.T206M mutation in the proband's sister confirmed a diagnosis of GCK-MODY. Her daughter was diagnosed at 16 weeks with permanent neonatal diabetes (PNDM). Mutation analysis identified two GCK mutations that were inherited in trans-p. [(R43P);(T206M)], confirming a diagnosis of GCK-PNDM. Both mutations were shown to be kinetically inactivating. The proband's mother, other sister, and daughter all had a clinical diagnosis of type 1 diabetes, confirmed by undetectable C-peptide levels and β-cell antibody positivity. GCK mutations were not detected. CONCLUSIONS: Two previously misclassified family members were shown to have GCK-MODY, whereas another was shown to have GCK-PNDM. A diagnosis of type 1 diabetes was confirmed in three relatives. This family exemplifies the importance of careful phenotyping and systematic evaluation of relatives after discovering monogenic diabetes in an individual.
spellingShingle Kavvoura, F
Raimondo, A
Thanabalasingham, G
Barrett, A
Webster, A
Shears, D
Mann, N
Ellard, S
Gloyn, A
Owen, K
Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.
title Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.
title_full Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.
title_fullStr Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.
title_full_unstemmed Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.
title_short Reclassification of diabetes etiology in a family with multiple diabetes phenotypes.
title_sort reclassification of diabetes etiology in a family with multiple diabetes phenotypes
work_keys_str_mv AT kavvouraf reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT raimondoa reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT thanabalasinghamg reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT barretta reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT webstera reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT shearsd reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT mannn reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT ellards reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT gloyna reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT owenk reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes